drugset / Trial / NCT01259648
Study Evaluating the Efficacy and Safety of Remifentanil in a Rapid Sequence Induction for Fragile Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary objective is to determine whether, during a rapid sequence intubation by etomidate, and succinylcholine Sellick maneuver, the administration of remifentanil at 2 different dosages (0.5 and 1.0 microgram per kg body weight), reduces potentially dangerous reactional tachycardia.
Timeline
- Start
- 2011-03-09
- Primary completion
- 2014-05-20
- Completion
- 2014-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remifentanil | Small molecule | 0.5 ug/kg | — |
| Subject | Remifentanil | Small molecule | 1 ug/kg | — |